---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-21-033451"
form_type: "8-K"
ticker: "NUS"
cik: "0001021561"
company_name: "NU SKIN ENTERPRISES, INC."
filed_at: "2021-10-04T23:59:59+00:00"
generated_at: "2026-06-28T23:15:43.324580+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Nu Skin estimates Q3 revenue $637-642M, below expectations due to delta variant disruptions

## Summary
- Estimated Q3 2021 revenue between $637M and $642M, softer than anticipated.
- Delta variant caused unexpected disruptions, especially in Mainland China and Southeast Asia, impacting sales and promotions.
- U.S. Collagen+ launch drove strong growth; Tencent digital tools introduced in China during the quarter.
- Full Q3 results and revised 2021 guidance to be announced on November 3, 2021.
- Annual 2021 revenue expected to be up modestly year over year, management remains confident in strategy.

## SEC filing metadata
- accession: 0001140361-21-033451
- form_type: 8-K
- ticker: NUS
- cik: 0001021561
- company_name: NU SKIN ENTERPRISES, INC.
- filed_at: 2021-10-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1021561/000114036121033451/0001140361-21-033451-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1021561/000114036121033451/brhc10029555_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-21-033451
- JSON: https://secwatch.observer/filing/0001140361-21-033451.json
- Plain text: https://secwatch.observer/filing/0001140361-21-033451.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.